Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
Lipella Pharmaceuticals (Nasdaq: LIPO), a clinical-stage biotechnology company, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. CEO Jonathan Kaufman, PhD, will be presenting at the event on Thursday, October 17th, 2024, at 10:30am.
The summit is scheduled to take place from October 15-17, 2024. Interested parties can access the webcast of Lipella's presentation at https://m-vest.com/events/healthcare-10152024. Additionally, Dr. Kaufman will be available for one-on-one meetings with registered investors attending the conference.
Lipella Pharmaceuticals focuses on developing treatments for serious diseases with significant unmet needs, positioning itself as a key player in the biotechnology sector.
Lipella Pharmaceuticals (Nasdaq: LIPO), una compagnia biotecnologica in fase clinica, ha annunciato la sua partecipazione al 2024 Maxim Healthcare Virtual Summit. Il CEO Jonathan Kaufman, PhD, presenterà all'evento giovedì, 17 ottobre 2024, alle 10:30.
Il summit è previsto dal 15 al 17 ottobre 2024. Le parti interessate possono accedere alla diretta streaming della presentazione di Lipella all'indirizzo https://m-vest.com/events/healthcare-10152024. Inoltre, il Dr. Kaufman sarà disponibile per incontri one-on-one con gli investitori registrati che partecipano alla conferenza.
Lipella Pharmaceuticals si concentra sullo sviluppo di trattamenti per malattie gravi con significative necessità insoddisfatte, posizionandosi come un attore chiave nel settore biotecnologico.
Lipella Pharmaceuticals (Nasdaq: LIPO), una empresa de biotecnología en etapa clínica, ha anunciado su participación en el 2024 Maxim Healthcare Virtual Summit. El CEO Jonathan Kaufman, PhD, presentará en el evento el jueves 17 de octubre de 2024, a las 10:30 am.
El cumbre está programado para llevarse a cabo del 15 al 17 de octubre de 2024. Las partes interesadas pueden acceder a la transmisión del evento de Lipella en https://m-vest.com/events/healthcare-10152024. Además, el Dr. Kaufman estará disponible para reuniones uno a uno con inversores registrados que asistan a la conferencia.
Lipella Pharmaceuticals se centra en desarrollar tratamientos para enfermedades graves con necesidades importantes no satisfechas, posicionándose como un actor clave en el sector biotecnológico.
리펠라 제약회사 (Nasdaq: LIPO)는 임상 단계의 바이오 기술 회사로, 2024 맥심 헬스케어 가상 정상 회담에 참여한다고 발표했습니다. CEO 조나단 카우프만, PhD가 2024년 10월 17일 목요일 오전 10시 30분에 행사에서 발표할 예정입니다.
이번 정상 회담은 2024년 10월 15일부터 17일까지 진행될 예정입니다. 관심이 있는 당사자는 Lipella의 발표를 https://m-vest.com/events/healthcare-10152024에서 생중계로 시청할 수 있습니다. 또한 카우프만 박사는 회의에 참석하는 등록된 투자자와의 일대일 미팅을 위해 자리를 마련할 것입니다.
리펠라 제약회사는 중대한 unmet need가 있는 치료제 개발에 집중하며 바이오 기술 분야에서 중요한 역할을 하는 회사로 자리 잡고 있습니다.
Lipella Pharmaceuticals (Nasdaq: LIPO), une société de biotechnologie en phase clinique, a annoncé sa participation au 2024 Maxim Healthcare Virtual Summit. Le PDG Jonathan Kaufman, PhD présentera lors de l'événement le jeudi 17 octobre 2024, à 10h30.
Le sommet est prévu du 15 au 17 octobre 2024. Les parties intéressées peuvent accéder au webcast de la présentation de Lipella à l'adresse https://m-vest.com/events/healthcare-10152024. De plus, le Dr Kaufman sera disponible pour des réunions en tête-à-tête avec des investisseurs inscrits participant à la conférence.
Lipella Pharmaceuticals se concentre sur le développement de traitements pour des maladies graves ayant des besoins non satisfaits significatifs, se positionnant comme un acteur clé dans le secteur de la biotechnologie.
Lipella Pharmaceuticals (Nasdaq: LIPO), ein Biotechnologieunternehmen in der klinischen Phase, hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit angekündigt. CEO Jonathan Kaufman, PhD, wird am Donnerstag, den 17. Oktober 2024, um 10:30 Uhr auf der Veranstaltung präsentieren.
Der Gipfel ist für den 15. bis 17. Oktober 2024 angesetzt. Interessierte Parteien können die Übertragung der Präsentation von Lipella unter https://m-vest.com/events/healthcare-10152024 ansehen. Darüber hinaus wird Dr. Kaufman für eins-zu-eins-Gespräche mit registrierten Investoren, die an der Konferenz teilnehmen, zur Verfügung stehen.
Lipella Pharmaceuticals konzentriert sich auf die Entwicklung von Behandlungsmöglichkeiten für schwerwiegende Krankheiten mit erheblichen unerfüllten Bedürfnissen und positioniert sich als wichtiger Akteur im Bereich der Biotechnologie.
- None.
- None.
PITTSBURGH, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Maxim Healthcare Virtual Summit that is being held on October 15 -17, 2024.
Event: Lipella Presentation - 2024 Maxim Healthcare Virtual Summit
Date: Thursday, October 17th, 2024
Time: 10:30am
Webcast: https://m-vest.com/events/healthcare-10152024
Jonathan Kaufman will be available for one-on-one meetings with registered investors of the conference.
About Lipella Pharmaceuticals
Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Additionally, Lipella maintains a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists. Lipella completed its initial public offering in December 2022. For more information, please visit www.lipella.com or LinkedIn
CONTACT
Jeff Ramson
PCG Advisory
jramson@pcgadvisory.com
646-863-6893
FAQ
When is Lipella Pharmaceuticals (LIPO) presenting at the 2024 Maxim Healthcare Virtual Summit?
Who will be representing Lipella Pharmaceuticals (LIPO) at the 2024 Maxim Healthcare Virtual Summit?
How can investors access Lipella Pharmaceuticals' (LIPO) presentation at the 2024 Maxim Healthcare Virtual Summit?
What are the dates for the 2024 Maxim Healthcare Virtual Summit featuring Lipella Pharmaceuticals (LIPO)?
Will Lipella Pharmaceuticals (LIPO) be offering one-on-one meetings at the 2024 Maxim Healthcare Virtual Summit?
